Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
65 studies found for:    cdc7
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated A Study of BMS-863233 in Patients With Hematologic Cancer
Condition: Refractory Hematologic Cancer
Intervention: Drug: Cdc7-inhibitor (BMS-863233)
2 Terminated A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Conditions: Advanced Solid Cancers;   Metastatic Cancer
Intervention: Drug: Cdc7-inhibitor
3 Terminated Study of NMS-1116354 in Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: NMS-1116354
4 Terminated Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Intervention: Drug: NMS-1116354
5 Completed
Has Results
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
Condition: Smoking Cessation
Intervention: Drug: Varenicline
6 Completed Pneumococcal Adult-dose Ranging Immunization Study
Condition: Pneumonia
Interventions: Biological: PCV7, Prevnar®;   Biological: Pneumovax 23
7 Completed CDC Anthrax Vaccine Clinical Trial
Condition: Healthy
Intervention: Biological: BioThrax or Anthrax Vaccine Adsorbed
8 Completed Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7
Condition: Infectious Disease
Intervention: Biological: 7-valent pneumococcal conjugated vaccine
9 Active, not recruiting Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
Conditions: Staphylococcal Infections;   Meningitis;   Sepsis;   Pneumonia
Interventions: Drug: Cotrimoxazole;   Drug: Vancomycin
10 Not yet recruiting Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine
11 Completed Adherence With Iron Sprinkles Among High-Risk Infants
Conditions: Anemia;   Iron Deficiency
Interventions: Drug: Ferrous sulphate drops with vitamins A, D, and C;   Drug: Ferrous fumarate sprinkles with vitamins and minerals
12 Completed Efficacy of Alcohol Hand-rubbing Covering All Hand Surfaces in Reducing Bacterial Hand Contamination of Healthcare Staff
Condition: Efficacy of Hand Hygiene Protocols
Intervention: Other: Hand hygiene protocol
13 Completed
Has Results
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
Condition: Leukaemia, Lymphocytic, Chronic
Intervention: Drug: ofatumumab 100 mg, 1000 mg / vial
14 Not yet recruiting Dating Matters: Strategies to Promote Healthy Teen Relationships
Conditions: Teen Dating Violence;   Healthy Dating Relationship Behaviors
Interventions: Behavioral: Dating Matters Comprehensive Approach;   Behavioral: Standard of Care Safe Dates Approach
15 Completed
Has Results
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria
Condition: Pneumococcal Infections
Intervention: Biological: Prevenar
16 Completed A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Condition: Solid Tumors
Interventions: Drug: MK1775;   Drug: gemcitabine;   Drug: cisplatin;   Drug: carboplatin
17 Completed
Has Results
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
Conditions: Bacterial Vaginosis;   Vaginal Discharge
Intervention: Drug: Metronidazole
18 Completed
Has Results
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults
Condition: Influenza
Interventions: Biological: High Dose Trivalent Inactivated Influenza Vaccine;   Biological: Trivalent Inactivated Influenza Vaccine
19 Unknown  Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
Condition: Influenza
Intervention: Biological: inactivated influenza A/H5N1 vaccine
20 Completed Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
Condition: Pneumococcal Infections
Interventions: Biological: Tetanus-diphtheria toxoids (Td);   Biological: 7-valent pneumococcal conjugate vaccine;   Biological: 23-valent polysaccharide vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years